UPDATE : Tuesday, March 19, 2019
Pharmbio Korea to develop antifungal drug with BioSynectics’ nanotechnology by Lee Han-soo 2019-03-13 17:48
YD Life Science to distribute Fresenius Kabi’s cell-processing system by Lee Han-soo 2019-03-13 16:35
Daewoong to enter P3 trial for Nabota in China by Lee Han-soo 2019-03-13 15:43
Regulator OKs Yuyu’s P2 clinical trial into dry eye treatment by Lee Han-soo 2019-03-13 12:43
GemVax & KAEL completes patient enrollment for P2 clinical trial into GV1001 by Lee Han-soo 2019-03-13 10:49
Dong-A ST’s erectile dysfunction treatment improves postmicturition dribbling by Lee Han-soo 2019-03-12 18:02
ImmuneOncia ends P1 clinical trials for solid cancer treatment by Lee Han-soo 2019-03-12 17:46
EU Gateway Healthcare exhibit opens for 2-day run in Seoul by Lee Han-soo 2019-03-12 15:59
Regulator OKs Humedix’s osteoarthritis treatment by Lee Han-soo 2019-03-12 13:55
HanAll starts P3 clinical trials for dry eye treatment in US by Lee Han-soo 2019-03-12 10:41
‘Proton therapy increases survival rate of liver cancer patients’ by Lee Han-soo 2019-03-11 17:01
LSK Global PS sets up subsidiary by Lee Han-soo 2019-03-11 15:14
LG Chem to develop sextuple influenza vaccine by Lee Han-soo 2019-03-11 14:31
Jeil releases P3 clinical trial results for anti-hypertension treatment by Lee Han-soo 2019-03-11 14:03
ResMed acquires HB Healthcare by Lee Han-soo 2019-03-08 17:49
Daewoong’s pulmonary fibrosis treatment wins government support by Lee Han-soo 2019-03-08 16:57
Yonsei, AITRICS to establish AI-based emergency prediction system by Lee Han-soo 2019-03-08 16:09
Gilead, Yuhan to co-promote Biktarvy by Lee Han-soo 2019-03-08 15:32
Roche Korea’s combo therapy gets nod as 1st-line lung cancer therapy by Lee Han-soo 2019-03-08 14:38
Sanofi Genzyme’s Gaucher disease treatment gets more insurance benefit by Lee Han-soo 2019-03-07 16:22
Back to Top